221 related articles for article (PubMed ID: 25753634)
21. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease.
Gochi M; Takayanagi N; Kanauchi T; Ishiguro T; Yanagisawa T; Sugita Y
BMJ Open; 2015 Aug; 5(8):e008058. PubMed ID: 26246077
[TBL] [Abstract][Full Text] [Related]
22. Therapy of nontuberculous mycobacterial disease.
Griffith DE
Curr Opin Infect Dis; 2007 Apr; 20(2):198-203. PubMed ID: 17496580
[TBL] [Abstract][Full Text] [Related]
23. Comparison of treatment outcomes between intermittent and daily regimens in non-cavitary nodular bronchiectatic-type
Jung J; Chong YP; Lee HJ; Shim TS; Jo K-W
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0100323. PubMed ID: 37843254
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species.
Boyle DP; Zembower TR; Reddy S; Qi C
Am J Respir Crit Care Med; 2015 Jun; 191(11):1310-7. PubMed ID: 25835090
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Mycobacterium avium Complex Pulmonary Disease: When Should I Treat and What Therapy Should I Start?
Nguyen MH; Daley CL
Clin Chest Med; 2023 Dec; 44(4):771-783. PubMed ID: 37890915
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Treatment Outcomes of Patients with Macrolide-Resistant Mycobacterium massiliense Lung Disease.
Choi H; Kim SY; Lee H; Jhun BW; Park HY; Jeon K; Kim DH; Huh HJ; Ki CS; Lee NY; Lee SH; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872066
[TBL] [Abstract][Full Text] [Related]
27. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
Ye JJ; Wu TS; Chiang PC; Lee MH
J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of
Koh WJ; Moon SM; Kim SY; Woo MA; Kim S; Jhun BW; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Chung MJ; Lee KS; Shin SJ; Daley CL; Kim H; Kwon OJ
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28954780
[TBL] [Abstract][Full Text] [Related]
29. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.
Lee G; Lee KS; Moon JW; Koh WJ; Jeong BH; Jeong YJ; Kim HJ; Woo S
Ann Am Thorac Soc; 2013 Aug; 10(4):299-306. PubMed ID: 23952847
[TBL] [Abstract][Full Text] [Related]
30. Treatment Outcomes of Mycobacterium avium Complex Lung Disease: A Systematic Review and Meta-analysis.
Kwak N; Park J; Kim E; Lee CH; Han SK; Yim JJ
Clin Infect Dis; 2017 Oct; 65(7):1077-1084. PubMed ID: 28582488
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ
Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282
[TBL] [Abstract][Full Text] [Related]
32. Relapse versus Reinfection of Mycobacterium avium Complex Pulmonary Disease. Patient Characteristics and Macrolide Susceptibility.
Boyle DP; Zembower TR; Qi C
Ann Am Thorac Soc; 2016 Nov; 13(11):1956-1961. PubMed ID: 27599038
[TBL] [Abstract][Full Text] [Related]
33. Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
Morimoto K; Namkoong H; Hasegawa N; Nakagawa T; Morino E; Shiraishi Y; Ogawa K; Izumi K; Takasaki J; Yoshiyama T; Hoshino Y; Matsuda S; Hayashi Y; Sasaki Y; Ishii M; Kurashima A; Nishimura T; Betsuyaku T; Goto H;
Ann Am Thorac Soc; 2016 Nov; 13(11):1904-1911. PubMed ID: 27513168
[TBL] [Abstract][Full Text] [Related]
34. [Clinical study on development of nontuberculous mycobacterial lung disease].
Kurashima A
Kekkaku; 2004 Dec; 79(12):737-41. PubMed ID: 15782619
[TBL] [Abstract][Full Text] [Related]
35. Changes in Serum IgA Antibody Levels against the Glycopeptidolipid Core Antigen during Antibiotic Treatment of Mycobacterium avium Complex Lung Disease.
Jhun BW; Kim SY; Park HY; Jeon K; Shin SJ; Koh WJ
Jpn J Infect Dis; 2017 Sep; 70(5):582-585. PubMed ID: 28367886
[TBL] [Abstract][Full Text] [Related]
36. Microbiological Persistence in Patients With Mycobacterium avium Complex Lung Disease: The Predictors and the Impact on Radiographic Progression.
Pan SW; Shu CC; Feng JY; Wang JY; Chan YJ; Yu CJ; Su WJ
Clin Infect Dis; 2017 Sep; 65(6):927-934. PubMed ID: 28541556
[TBL] [Abstract][Full Text] [Related]
37. Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
Koh WJ; Jeong BH; Jeon K; Park HY; Kim SY; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL
Antimicrob Agents Chemother; 2015 Aug; 59(8):4994-6. PubMed ID: 25987622
[TBL] [Abstract][Full Text] [Related]
38. Multiplex cytokine analysis in Mycobacterium avium complex lung disease: relationship between CXCL10 and poor prognostic factors.
Bamba Y; Moro H; Aoki N; Koizumi T; Ohshima Y; Watanabe S; Sakagami T; Koya T; Takada T; Kikuchi T
BMC Infect Dis; 2019 Mar; 19(1):263. PubMed ID: 30885152
[TBL] [Abstract][Full Text] [Related]
39. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Watanabe M; Hasegawa N; Ishizaka A; Asakura K; Izumi Y; Eguchi K; Kawamura M; Horinouchi H; Kobayashi K
Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
